Doctor Yury Mareev

Doctor Yury Mareev

Rambam Health Care Campus, Haifa (Israel)

Member of:

Yura Mareev currently works at the National Medical Research Center for Preventive Medicine (Moscow) and Robertson Centre for Biostatistics, University of Glasgow (Glasgow). Yura does research in Cardiology.

Presentations

Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?

Event: Heart Failure 2021

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial Fibrillation and Device Therapy

Access

The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Can we teach heart failure drugs new tricks?

Access

Do patients with midterm HF have profile like HFrEF or HFpEF or they have their individual profile. Data from Russian national register 2012

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Population studies / Epidemiology

Session: Population studies - Epidemiology

Access

Why don't beta-blockers work in patients with heart failure and atrial fibrillation? Pauses?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation

Access

New clinical assessment scale - useful tool to analysis effect of treatment and prognosis of patients with heart failure

Event: HEART FAILURE 2016

Topic: Prognosis

Session: Prognosis

Access

Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial

Event: HEART FAILURE 2016

Topic: Diuretics

Session: Diuretics and fluid status management

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Yury Mareev

Biography

Contributor content

Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?

The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Do patients with midterm HF have profile like HFrEF or HFpEF or they have their individual profile. Data from Russian national register 2012

Why don't beta-blockers work in patients with heart failure and atrial fibrillation? Pauses?

New clinical assessment scale - useful tool to analysis effect of treatment and prognosis of patients with heart failure

Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial

ESC 365 is supported by

Doctor Yury Mareev Follow

Biography

Contributor content

Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?

The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Do patients with midterm HF have profile like HFrEF or HFpEF or they have their individual profile. Data from Russian national register 2012

Why don't beta-blockers work in patients with heart failure and atrial fibrillation? Pauses?

New clinical assessment scale - useful tool to analysis effect of treatment and prognosis of patients with heart failure

Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial

ESC 365 is supported by

Doctor Yury Mareev